Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization
about
Quantitative determination of irinotecan and the metabolite SN-38 by nanoflow liquid chromatography-tandem mass spectrometry in different regions of multicellular tumor spheroids.Mass spectrometry in the pharmacokinetic studies of anticancer natural products.Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1.Antineoplastic drugs and their analysis: a state of the art review.HPLC analysis and extraction method of SN-38 in brain tumor model after injected by polymeric drug delivery system.Development and validation of a microfluidic chip-based nano-liquid chromatography-triple quadrupole tandem mass spectrometry method for a sensitive and reliable quantification of 7-ethyl-10-hydroxycamptothecin (SN38) in mouse plasma.A rapid, simple and reliable HPLC-triple quadrupole tandem mass spectrometer method for a simultaneous quantification of irinotecan and its active metabolite 7-ethyl-10-hydroxycamptothecin (SN38) in mouse plasma.
P2860
Q35181116-B207190D-E16A-4E35-B9BC-FA40B4B858F2Q38568180-252ED496-5913-4C28-AEEB-6F00F61A6739Q38770075-2BCE9297-0F1C-4406-8667-96440CE551AFQ38981028-76EDCC30-F953-4B7A-B07E-C2174179B44BQ39339684-D34F181E-714E-4215-99C9-31BA9043A03DQ48680971-AF01B343-C71B-4AFB-9BE7-5BF2242ECB55Q51527478-95586F29-7470-4971-8789-9FF44266F35BQ53298941-573B790D-EFF6-46A0-ABEF-3E1168DF6306
P2860
Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Quantification of irinotecan, ...... n to hepatic chemoembolization
@ast
Quantification of irinotecan, ...... n to hepatic chemoembolization
@en
type
label
Quantification of irinotecan, ...... n to hepatic chemoembolization
@ast
Quantification of irinotecan, ...... n to hepatic chemoembolization
@en
prefLabel
Quantification of irinotecan, ...... n to hepatic chemoembolization
@ast
Quantification of irinotecan, ...... n to hepatic chemoembolization
@en
P2093
P2860
P1476
Quantification of irinotecan, ...... n to hepatic chemoembolization
@en
P2093
Cody J Peer
Raul Alfaro
Shawn D Spencer
William D Figg
Xiaohong Chen
P2860
P304
P356
10.1016/J.JPBA.2012.01.008
P577
2012-01-16T00:00:00Z